LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced an extraordinary general meeting scheduled for December 10, 2024, to discuss and approve the Entrusted Products Related Framework Agreement with Lepu Medical. The resolution will address transactions and proposed annual caps through the end of 2027, seeking shareholder confirmation and authorization. This meeting is a crucial event for stakeholders as it influences the company’s strategic partnerships and financial outlook.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.